Skip to content
Review Open access

AI safety evaluation in an underrepresented population: real-world performance of clinical decision support and frontier language models on Medicaid patient messaging triage

Aug 2026 · BMC Medical Informatics and Decision Making · 0 citations

TL;DR

No evaluated tool or combination was sufficiently accurate to enable physician-unassisted triage in this setting of patient-initiated text messages in a multi-state Medicaid population.

Abstract

Studies of artificial intelligence tools used in patient triage have largely involved academic medical center cohorts, scripted patient-actor scenarios, or knowledge benchmarks. Populations that may rely on such tools due to constrained access to in-person care, including Medicaid patients, have been less fully evaluated. To compare combinations of safety guardrails added to artificial intelligence tools for triage of patient-initiated text messages in a multi-state Medicaid population. Retrospective evaluation of 2000 messages from Medicaid patients across three U.S. states (Virginia, Washington, Ohio) during January 2023 through November 2025. Three physicians independently adjudicated each message under blinded review; disagreements were resolved by majority and a senior-physician arbiter. Tools included a deployed decision support system with a Conservative Q-Learning controller, supervised baselines (XGBoost+sentence-BERT, logistic regression, rule-based guardrails), and frontier large language models (Claude Opus 4.7, GPT-5.5, Gemini 3.1 Pro, each with and without retrieval-augmented generation). Combinations spanned single tools, ensembles, cascades, multi-model consensus rules, and four-component guardrail compositions identified by a structured literature review. Thresholds and Platt calibration were fit on a held-out validation split and frozen before the test pass. Two pre-specified targets: an autonomous (physician-unassisted) triage benchmark of sensitivity and specificity both 0.80 or higher; and a sensitivity-floor target of 0.80 to 0.95 with clinician review of flagged messages. Real-world messages had lower reading level (grade 4.6 versus 5.8) and more colloquialisms (59.1% versus 19.5%) than physician-scripted scenarios. Hazard prevalence on blinded physician review was 8.2% (165 of 2000). Two configurations met the sensitivity-floor target: a high-recall first-stage screen (sensitivity 0.855; 12.0 missed hazards and 729 alerts per 1,000 messages) and a disagreement-stratified clinician-review workflow (sensitivity 0.939; 5.0 missed hazards and 878 alerts per 1,000 messages). No configuration met the autonomous benchmark; sensitivity and specificity reached 0.594 and 0.592 for the best balanced single tool, 0.685 and 0.575 for the best balanced ensemble, and 0.297 and 0.874 for the highest-specificity cascade. No evaluated tool or combination was sufficiently accurate to enable physician-unassisted triage in this setting. Two configurations met the pre-specified sensitivity-floor target under clinician review of flagged messages, following the classical clinical-screening pattern.

Read PDF

Similar papers

Open access Jul 2026

Bedside Triage by Large Language Models in Acute Pancreatitis: A Scenario-Based Comparative Evaluation of GPT-4, GPT-5, and Gemini.

In this scenario-based early evaluation, GPT-5 was the most safety-aligned model, GPT-4 was the most operationally actionable, and Gemini was strongest for synthesis, but all require clinician oversight, prospective validation, and governance before clinical deployment.

Y. K. Çalışkan, Fatih Başak, Olgun Erdem · 0 citations
Open access Jul 2026

Profile-associated financial and access-related framing in LLM-generated pediatric asthma referral plans: a factorial audit of seven large language models

LLM-generated pediatric asthma referral plans varied in financial-access, geographic-access, navigation, SDOH-recognition, and selected tone-related framing, which support evaluating structural and access-related framing alongside biomedical content in clinical LLM audits.

Zhendong Liu, Xiaoping Yang, Yu Zhang et al. · 0 citations
Jul 2026

When 99.98% is too Good to be True: Preventing Rule-Induced Overfitting in Embodied Clinical AI for Surgical Readmission Prediction

Embodied Artificial Intelligence (AI) systems are increasingly used to support clinical decision-making, telemedicine follow-up, and resource allocation, particularly in remote and resource-constrained healthcare settings. In these deployments, predictive models are embedded within clinical workflows and operate under...

Antoine B. Bagula, Landry Mbale, Olasupo O. Ajayi et al. · 0 citations
Open access Jul 2026

AI-enabled clinical decision support in breast cancer care: a blinded multicenter benchmarking study comparing medically specialized with a general-purpose system

The results indicate that while regulatory clearance and domain specialization address key requirements for AI-enabled clinical decision support systems, these factors alone do not translate into superior performance in breast cancer care.

Jonas Freudenberg, J. Knitza, N. Gremke et al. · 0 citations
Open access Jul 2026

Evaluating Large Language Models for AI-Assisted Decision Support in Legal Capacity Assessment: A Comparative Study Using Interdisciplinary Medical Board Recommendations as the Expert Medical Reference Standard

LLMs demonstrated agreement with IMBD recommendations on standardized medico-legal case vignettes, supporting further investigation of their potential role as AI-assisted decision-support tools under expert supervision.

H. Aydoğan, Muhammet Sevindik, Zeynep Unat Öztürk et al. · 0 citations
Review Aug 2026

AI-Powered Prescription Error Detection Using Large Language Models (LLMs): A Systematic Review and Future Perspectives

It is concluded that LLM-based decision-support tools hold substantial promise as complementary — rather than autonomous — decision-support systems capable of transforming medication safety and pharmacy practice.

K. K. Kumar, Koyya Gowtham Reddy, K. Reddy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.